Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 136.55 USD | +0.20% |
|
-2.40% | +56.34% |
| Market Cap | 8.84B 7.89B 7.33B 6.67B 12.54B 837B 12.77B 88.05B 34.45B 437B 33.16B 32.46B 1,397B | P/E 2026 * |
30.3x | P/E 2027 * | -366x |
|---|---|---|---|---|---|
| Enterprise Value | 8.31B 7.42B 6.89B 6.27B 11.8B 787B 12.01B 82.8B 32.4B 411B 31.18B 30.52B 1,314B | EV / Sales 2026 * |
15.3x | EV / Sales 2027 * | 39.5x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | +0.20% | ||
| 1 week | -2.40% | ||
| Current month | -3.08% | ||
| 1 month | -4.78% | ||
| 3 months | +0.80% | ||
| 6 months | +29.50% | ||
| Current year | +56.34% |
| 1 week | 135.62 |  | 152.18 |
| 1 month | 134.1 | | 152.18 |
| Current year | 77 | | 160.81 |
| 1 year | 73.08 | | 160.81 |
| 3 years | 13.72 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Exercice | Chief Financial Officer | 175,887 | 0.2718% | ||
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.20% | -2.40% | +75.79% | +784.39% | 8.82B | |
| +0.21% | -4.63% | +55.34% | +71.32% | 68.92B | |
| +1.66% | +7.51% | +8.12% | +60.04% | 51.9B | |
| +3.14% | +7.17% | +12.48% | +44.42% | 48.73B | |
| +3.45% | +4.70% | +33.44% | +35.96% | 43.13B | |
| -2.20% | +0.61% | +281.88% | +532.76% | 41.48B | |
| +6.43% | +6.84% | +18.32% | +109.23% | 39.96B | |
| +1.28% | +1.39% | +11.69% | +45.10% | 30.6B | |
| -2.21% | -10.09% | +35.34% | -0.94% | 26.01B | |
| +1.74% | -2.02% | -13.55% | -12.92% | 22.27B | |
| Average | +1.37% | -1.18% | +51.88% | +166.94% | 38.18B | |
| Weighted average by Cap. | +1.55% | -0.32% | +53.31% | +120.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 542M 483M 449M 409M 769M 51.3B 783M 5.4B 2.11B 26.77B 2.03B 1.99B 85.65B | 211M 189M 175M 159M 300M 20.01B 305M 2.11B 824M 10.44B 793M 776M 33.41B |
| Net income | 317M 283M 263M 239M 450M 30B 458M 3.16B 1.23B 15.65B 1.19B 1.16B 50.08B | -24.17M -21.57M -20.05M -18.24M -34.31M -2.29B -34.93M -241M -94.22M -1.19B -90.69M -88.77M -3.82B |
| Net Debt | -527M -470M -437M -398M -748M -49.91B -762M -5.25B -2.05B -26.04B -1.98B -1.94B -83.32B | -494M -441M -410M -373M -702M -46.81B -714M -4.92B -1.93B -24.42B -1.85B -1.82B -78.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | US$136.55 | +0.20% | 707,735 |
| 14/10/26 | US$136.28 | -1.60% | 679,101 |
| 13/10/26 | US$138.49 | -4.41% | 1,031,829 |
| 12/10/26 | US$144.88 | +0.80% | 898,518 |
| 09/10/26 | US$143.73 | +2.73% | 763,098 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
